¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

½ÉÀå´ë»çÁõÈıºÇÐȸ 2022 Ãß°è½ÉÆ÷Áö¾ö : 2022-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
½ÉÀå´ë»çÁõÈıºÇÐȸ 2022 Ãß°è½ÉÆ÷Áö¾ö : 2022-09-03
±³À°ÀÏÀÚ : 2022-09-03
±³À°Àå¼Ò : ½ºÀ§½º ±×·£µå È£ÅÚ (Çöó¹Ö°í·ë)  
±³À°ÁÖÁ¦ : ½ÉÀå´ë»çÁõÈıºÇÐȸ 2022 Ãß°è½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå´ë»çÁõÈıºÇÐȸ  
´ã´çÀÚ : ±è¼±¿Á
¿¬¶ôó : 02-2273-8556  
À̸ÞÀÏ : apcms@kscms.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í ±³¼ö ¹× °³¿øÀÇ: 4¸¸¿øÀü°øÀÇ, ÀüÀÓÀÇ, ±âŸ: 2¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 Flamingo room 09:00~09:20 Obesity and metabolic syndrome treatment with gut microbiome  È²¼º¼ø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-03 Flamingo room 09:20~09:40 Gut microbiome and inflammation : focus on clinical application  ±èºÀ¼ö(ÇѸ²´ë »ý¸í°úÇаú) 
±³À°½Ã°£ 09-03 Flamingo room 09:40~10:00 Gut microbiome and kidney  Á¶»ó°æ(°í·ÁÀÇ´ë) 
Åä·Ð 09-03 Flamingo room 10:00~10:20 Discussion  Á¶»óÈ£(ÇѸ²ÀÇ´ë) 
È޽Ġ09-03 Flamingo room 10:20~10:50 Coffee Break & Photo Time  () 
±³À°½Ã°£ 09-03 Flamingo room 10:50~11:10 Strategy to create value with biomedical data and AI at commercial level  ÃÖÈ«À±(Portrai, Inc) 
±³À°½Ã°£ 09-03 Flamingo room 11:10~11:30 Current status of big data application in industry  ÀÌÇнÂ(Medical AI) 
±³À°½Ã°£ 09-03 Flamingo room 11:30~11:50 The future of AI in diagnosis and treatment of heart and metabolic disease  Àå¹Î¿Á(VUNO) 
Åä·Ð 09-03 Flamingo room 11:50~12:10 Discussion  À̹ÎÈ£(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-03 Flamingo room 12:10~12:25 Cutting edge care of Pitavastatin with Ezetimibe combination therapy  ¼­¿ø¿ì(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 09-03 Flamingo room 12:25~12:40 Optimal BP control strategy for DM patients  Á¶µ¿Çõ(¿¬¼¼¿øÁÖÀÇ´ë) 
½Ä»ç 09-03 Flamingo room 12:40~13:30 Lunch  () 
±³À°½Ã°£ 09-03 Flamingo room 13:30~13:48 AI and cardiovascular medicine  À̽Âö(Æ÷Ç×°ø´ë ±â°è°øÇаú) 
±³À°½Ã°£ 09-03 Flamingo room 13:48~14:06 Metaverse in heart and metabolic disease treatment  À̾ð(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 09-03 Flamingo room 14:06~14:24 Apprehensions about Excessive Belief in Medical Big DATA : Points of Concern Excluding Merits  ±èÇ强(°¡Å縯ÀÇ´ë) 
Åä·Ð 09-03 Flamingo room 14:24~14:45 Discussion  ¹Ú¼º¹Ì(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-03 Flamingo room 14:45~15:03 Emerging new drug for dyslipidemia: ASO and siRNA , AGPTL3 peptide targeting mAb  À§Áø(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 09-03 Flamingo room 15:03~15:21 GIP and GLP-1 agonist combination  ±è¿øÁø(Â÷ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 09-03 Flamingo room 15:21~15:39 New drug for patients with resistant hypertension  Á¶À翵(Àü³²ÀÇ´ë) 
Åä·Ð 09-03 Flamingo room 15:39~16:00 Discussion  È«Áö¿¬(ÇѸ²ÀÇ´ë) 
È޽Ġ09-03 Flamingo room 16:00~16:15 Coffee Break  () 
±³À°½Ã°£ 09-03 Flamingo room 16:15~16:33 Vasospastic angina and atherosclerosis  ±èÇöÁø(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 09-03 Flamingo room 16:33~16:51 TG rich lipoprotein and atherosclerotic CVD  ÇãÁöÇý(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 09-03 Flamingo room 16:51~17:09 Atherosclerotic disease after recovery COVID 19 infection  À念¿ì(°¡ÃµÀÇ´ë) 
Åä·Ð 09-03 Flamingo room 17:09~17:30 Discussion  ¹Ú¼¼Àº(¼º±Õ°üÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ½ÉÀå´ë»çÁõÈıºÇÐȸ 2022 Ãß°è½ÉÆ÷Áö¾ö : 2022-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŻý¾ÆÇÐȸ Á¦4Â÷ Neonatal Echocardiography Hands-on Course : 2022-09-03
´ÙÀ½±Û 2022³â °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø¡¤´ëÇÑÀ̽ÄÇÐȸ ¡®±è¼öȯÃß±â°æ ±â³ä¡¯ °øµ¿ÁÖÃÖ ½ÉÆ÷Áö¾ö : 2022-09-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 6 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 8 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 113 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 21 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 77 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 13 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 10 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 8 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 28 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 5 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 10 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 2 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 11 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 9 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 12 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷